Panel Discussion: Creating an Open Dialogue Between People Living with ALS & Drug Developers to Co-ordinate Therapeutic Development Priorities

Time: 2:45 pm
day: Day Two AM


  • Hearing directly from people living with ALS – what are the most important priorities in ALS drug development?
  • Discussing participant engagement and experiences from most recent clinical trials – what improvements can be made?
  • Identifying the immediate impacts people living with ALS are looking for from novel drug development